Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.03 Billion CNY | -48.76% |
| 2022 | 3.98 Billion CNY | 237.95% |
| 2021 | 1.17 Billion CNY | 17.91% |
| 2020 | 999 Million CNY | 13.87% |
| 2019 | 877.35 Million CNY | 20.41% |
| 2018 | 728.64 Million CNY | 37.46% |
| 2017 | 530.06 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 523.86 Million CNY | 21.92% |
| 2024 Q1 | 429.66 Million CNY | -14.82% |
| 2024 Q3 | 433.82 Million CNY | -17.19% |
| 2023 Q2 | 414.97 Million CNY | -37.13% |
| 2023 FY | 2.03 Billion CNY | -48.76% |
| 2023 Q3 | 469.96 Million CNY | 13.25% |
| 2023 Q1 | 659.99 Million CNY | -22.51% |
| 2023 Q4 | 504.41 Million CNY | 7.33% |
| 2022 Q2 | 967.11 Million CNY | -29.4% |
| 2022 FY | 3.98 Billion CNY | 237.95% |
| 2022 Q4 | 851.76 Million CNY | 7.55% |
| 2022 Q1 | 1.36 Billion CNY | 327.07% |
| 2022 Q3 | 791.95 Million CNY | -18.11% |
| 2021 Q1 | 235.56 Million CNY | -18.78% |
| 2021 FY | 1.17 Billion CNY | 17.91% |
| 2021 Q4 | 320.76 Million CNY | 3.77% |
| 2021 Q2 | 312.44 Million CNY | 32.64% |
| 2021 Q3 | 309.12 Million CNY | -1.06% |
| 2020 Q2 | 301.65 Million CNY | 137.5% |
| 2020 Q4 | 290.04 Million CNY | 3.48% |
| 2020 FY | 999 Million CNY | 13.87% |
| 2020 Q3 | 280.29 Million CNY | -7.08% |
| 2020 Q1 | 127.01 Million CNY | 0.0% |
| 2019 FY | 877.35 Million CNY | 20.41% |
| 2018 FY | 728.64 Million CNY | 37.46% |
| 2017 FY | 530.06 Million CNY | 0.0% |